.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Queensland Health
Cerilliant
Moodys
Dow
Johnson and Johnson
Cipla
Merck
Argus Health

Generated: July 25, 2017

DrugPatentWatch Database Preview

Nitazoxanide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nitazoxanide and what is the scope of nitazoxanide patent protection?

Nitazoxanide
is the generic ingredient in one branded drug marketed by Romark and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Nitazoxanide has one hundred and twenty-three patent family members in forty-two countries.

There are four drug master file entries for nitazoxanide. Three suppliers are listed for this compound.

Summary for Generic Name: nitazoxanide

Tradenames:1
Patents:3
Applicants:1
NDAs:2
Drug Master File Entries: see list4
Suppliers / Packagers: see list3
Bulk Api Vendors: see list76
Clinical Trials: see list44
Patent Applications: see list1,575
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nitazoxanide at DailyMed

Pharmacology for Ingredient: nitazoxanide

Drug ClassAntiprotozoal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Romark
ALINIA
nitazoxanide
TABLET;ORAL021497-001Jul 21, 2004RXYesYes► Subscribe► SubscribeY ► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nitazoxanide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
TABLET;ORAL021497-001Jul 21, 2004► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
TABLET;ORAL021497-001Jul 21, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: nitazoxanide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,020,353 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide► Subscribe
5,387,598 Composition and galenic formulation suitable for combatting affections of the lower abdomen► Subscribe
5,856,348 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide► Subscribe
5,886,013 Antiviral composition► Subscribe
5,859,038 Method for treatment of helicobacter pylori infections► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: nitazoxanide

Country Document Number Estimated Expiration
Hungary0003330► Subscribe
Georgia, Republic ofP20032970► Subscribe
African Regional IP Organization (ARIPO)9600866► Subscribe
Czech Republic9602959► Subscribe
Canada2182228► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
US Department of Justice
McKesson
Accenture
Deloitte
Baxter
Teva
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot